Advertisement

Topics

BridgeBio Pharma Expands Investor Base, Raising An Additional $135 Million, And Discloses Genetic Disease Pipeline Programs

20:00 EDT 12 Sep 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: BridgeBio Pharma Expands Investor Base, Raising An Additional $135 Million, And Discloses Genetic Disease Pipeline Programs

NEXT ARTICLE

More From BioPortfolio on "BridgeBio Pharma Expands Investor Base, Raising An Additional $135 Million, And Discloses Genetic Disease Pipeline Programs"

Quick Search
Advertisement